<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:ifp="http://www.ifactory.com/press" xmlns:sm="http://www.sitemaps.org/schemas/sitemap/0.9">
  <ifp:contentType>ARTICLE</ifp:contentType>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p909.xml</sm:loc>
    <ifp:title>Lucky to Be an Oncologist</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p911.xml</sm:loc>
    <ifp:title>Major Response to Cyclophosphamide and Prednisone in Recurrent Castration-Resistant Prostate Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p917.xml</sm:loc>
    <ifp:title>Head and Neck Cancers, Version 2.2013</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p928.xml</sm:loc>
    <ifp:title>Determinants of Enrollment in Cancer Clinical Trials: The Relationship Between the Current State of Knowledge, Societal Disease Burden, and Randomized Clinical Trial Enrollment</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p941.xml</sm:loc>
    <ifp:title>Diagnostic Strategies for Invasive Fungal Infections in Patients With Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p952.xml</sm:loc>
    <ifp:title>Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p968.xml</sm:loc>
    <ifp:title>Targeted Therapy in Relapsed Classical Hodgkin Lymphoma</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p977.xml</sm:loc>
    <ifp:title>Analysis of Circulating Tumor Cells in Breast Cancer</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p992.xml</sm:loc>
    <ifp:title>Adult Cancer Pain</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p1023.xml</sm:loc>
    <ifp:title>Opioid Misuse and Abuse: Risk Assessment and Management in Patients with Cancer Pain</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-p1034.xml</sm:loc>
    <ifp:title>Five Questions About the NCCN Foundation</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-pxxiv.xml</sm:loc>
    <ifp:title>NCCN News</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-pxxix.xml</sm:loc>
    <ifp:title>NCCN Guidelines® Updates</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/8/article-pxxxvi.xml</sm:loc>
    <ifp:title>Oncology Research Program</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
  <sm:url>
    <sm:loc>https://harbor-dev.pubfactory.com/view/journals/jnccn/11/suppl_3/article-pS-1.xml</sm:loc>
    <ifp:title>NCCN Task Force Report: Bone Health in Cancer Care</ifp:title>
    <sm:lastmod>2019-01-04</sm:lastmod>
  </sm:url>
</urlset>
